《Table 2Surgical outcomes of patients who underwent ABO-I LDLT.》

《Table 2Surgical outcomes of patients who underwent ABO-I LDLT.》   提示：宽带有限、当前游客访问压缩模式
本系列图表出处文件名：随高清版一同展现
《A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation》


  1. 获取 高清版本忘记账户？点击这里登录
  1. 下载图表忘记账户？点击这里登录
Values are presented as number（%），mean±SD or median（interquartile range）.ABO-I:ABO-incompatible；AMR:antibody-mediated rejection；BPACR:biopsy-proven acute cellular rejection；TIT:total ischemia time；CIT:cold ischemia time；WIT:warm ischemia time；EBL:est

Among the complications，biliary stricture was most common in both groups，occurring in 23.1%of patients（n=6）in the RP group and 16.7%of patients（n=5）in the RO group（P=0.990）.Meanwhile，all biliary strictures were observed at the anastomosis site，and diffuse intrahepatic biliary stricture was not observed.Hepatic artery thrombosis occurred in 6.7%of patients（n=2）in the RO group only.Infection occurred in 7.7%of patients（n=2）in the RP group and 6.7%of patients（n=2）in the RO group（P=0.791）（Table 2） .

图表编号XD0020450800    严禁用于非法目的
绘制时间2018.04.01
作者Eung Chang Lee、Seong Hoon Kim、Jae Ryong Shim、Sang-Jae Park
绘制单位Center for Liver Cancer, National Cancer Center、Center for Liver Cancer, National Cancer Center、Center for Liver Cancer, National Cancer Center、Center for Liver Cancer, National Cancer Center
更多格式高清、无水印（增值服务）

相关图表

  1. 《Table 9 Outcome of laparoscopic-assisted endoscopic retrograde cholangiopancreatography in patients undergoing Roux-en-Y》2019.07.14
  2. 《Table 3The second infusion of CAR T cells and patient outcomes.》2019.02.01
  3. 《Table 2The first infusion of CAR T cells and patient outcomes.》2019.02.01
  4. 《Table 2 Peer-reviewed literature reports on the clinical outcomes of patients undergoing endoscopic transluminal necrose》2019.04.27
  5. 《Table 1 Peer-reviewed literature reports on the clinical outcomes of patients undergoing percutaneous catheter drainage》2019.04.27
  6. 《Table 1 Clinical characteristics of patients who underwent fully covered self-expanding metal stent placement with or wi》2019.05.16
  7. 《Table 5.Secondary Treatment Outcomes of RUTI Patients[Case (%) ]》2019.01.01
  8. 《Table 4.Primary Treatment Outcomes of RUTI Patients[Case (%) ]》2019.01.01
  9. 《Table 1 Characteristics of patients who underwent R0 resection for gastric cancer n (%)》2019.01.14
  10. 《Table 2.Treatment, outcome and survival time of 13 induction-therapeutic patients》2019.02.20
  11. 《Table 2 Clinical characteristics of adult discharges with cholangitis who underwent endoscopic retrograde cholangiopancr》2019.01.16
  12. 《Table 5 Comparison of surgical outcomes between patients with absent and present SNAP》2019.03.01
  13. 《Table 1Baseline characteristics and procedural outcomes of patients who underwent EUS-TD for PCs due to AP.》2019.02.15
  14. 《Table 2 Surgical outcomes in patients with infantile esotropia who underwent bilateral medial rectus muscle recession be》2018.12.18
  15. 《Table 3 Surgical outcomes of patients with infantile esotropia who underwent bilateral medial rectus muscle recession be》2018.12.18
  16. 《Table 1 Demographic and clinical characteristics of patients with infantile esotropia who underwent bilateral medial rec》2018.12.18
  17. 《Table 2Clinical outcomes of enrolled patients.》2018.12.15
  18. 《Table 3Analysis of predictors of patient survival after ABO-I LDLT.》2018.04.01
  19. 《Table 1Basal characteristics of patients who underwent ABO-I LDLT.》2018.04.01
  20. 《Table 3Postoperative outcomes of the study patients.》2018.02.01

随机翻阅

《表2 地表热场等级划分：重庆市市域热场分布与土地利用的关联分析》 《表1 2组产妇满意度比较例（%）》 《表5 相容性试验分析结果》 《表1 主要研究者和研究机构》 《表1 纳入指南基本信息表》 《表6 新型干树储油半潜平台与传统平台对比》 《表4 椎动脉起始段重度狭窄行支架置入术后发生支架内再狭窄的多因素Cox逐步回归分析》 《表7 两组患者再住院率比较[例（%）]》 《表1 250例患者抗高血压药物使用情况 (n, %)》 《表2 两组患者不良反应发生情况比较[n (%) ]》